Liver Support Stack: 5 Evidence-Based Supplements + 6 to Cut

5 items. ~$105–175/month. Buy individually, not as a bundle.Stack-kit editorial

Your liver cleans your blood in two stages, all day, every day — no tea or pill "kickstarts" the process. Most "liver cleanse" products on the shelf help with neither stage. This protocol names the five supplements with documented mechanisms in Phase II conjugation — glutathionation, glucuronidation, methylation, sulfation (these are the four chemical reactions your liver uses to make toxins water-soluble so you can excrete them) — and cuts six categories of popular products that don't clear that bar.

TL;DR — The Protocol at a Glance

Key caveat: Liposomal glutathione is an upgrade tier — if budget constrains, NAC covers the same downstream pathway at lower cost. Lead with silymarin + NAC + methylated B + choline as the entry stack (~$70–90/month).

What we cut: detox teas, activated charcoal (daily), dandelion root, olive oil "gallbladder flushes," curcumin without a bioavailability system, and proprietary "liver support" blends at sub-threshold doses.

The Protocol — Detailed

How the Liver Actually Works (and What "Support" Means)

Here's the thing most liver-cleanse content quietly depends on you not knowing: the liver doesn't get "clogged" and it doesn't need to be "flushed." It runs a two-stage chemical assembly line, and the only honest version of "support" is making sure that line never runs short on raw material. Read this section once and most of the cut-list below becomes obvious on its own.

So, the assembly line. Your liver processes drugs, metabolic byproducts, and endogenous compounds — meaning the ones your own body produces, not just things you ingest — through two phases. Phase I (the CYP450 enzyme family) oxidizes compounds into water-soluble intermediates. Counterintuitively, those intermediates are often more reactive than the thing that went in. It's the reactive electrophiles — unstable, electron-hungry molecules — that stress your liver cells, not the original substrate. Phase I, left to itself, is the problem.

Phase II is the cleanup crew. It grabs those reactive intermediates and neutralizes them through six conjugation reactions — "conjugation" just means bolting on a small molecule to make the toxin safe and easy to pee out:

• Glutathionation (glutathione S-transferase)
• Glucuronidation (UDP-glucuronosyltransferase)
• Sulfation (sulfotransferases)
• Methylation (methyltransferases, SAMe-dependent)
• Acetylation (N-acetyltransferases)
• Amino acid conjugation (glycine, taurine)

The trouble starts when Phase II can't keep up with Phase I. That happens for three reasons — you're short on the raw materials those reactions burn through, you carry a genetic variant that slows an enzyme down, or your toxic load is simply too high — and often all three at once. When the cleanup crew falls behind, those reactive intermediates pile up. You can see the pileup in bloodwork as elevated ALT and AST (two liver enzymes that leak into the blood when liver cells are stressed), as fat infiltrating the liver, and, given enough time, as scarring.

Every item in this protocol earns its place one way: a cited mechanism in at least one Phase II pathway, or in the raw-material supply chain feeding those pathways. That was the entire filter. Couldn't clear it with human clinical data? It didn't make the stack. The five that did are below.

The 5-Item Liver Support Stack — Full Protocol

1. Silymarin (Milk Thistle, Standardized Extract)

In one line: the milk-thistle compound with actual human-trial backing for liver health — but only the standardized extract, not the bargain-bin powder.

Mechanism

Silymarin is the flavonolignan complex from Silybum marianum; the primary active compound is silybin. It works three documented ways:

1. Silybin inhibits hepatic uptake of toxins via organic anion-transporting polypeptides (OATPs) — in plain terms, it slows toxins at the door before Phase I ever loads them up.
2. It upregulates glutathione S-transferase, the Phase II glutathionation enzyme, so the cleanup crew has more capacity.
3. It stimulates RNA polymerase I, which drives hepatocyte protein synthesis and regenerative throughput — the liver rebuilds faster.

You can measure the downstream effect in some clinical contexts: ALT/AST can improve in people who started with elevated liver enzymes. And this isn't only a soft surrogate-marker story — the Wah Kheong RCT below included a histological endpoint, the kind read off an actual biopsy. That still does not make a consumer supplement protocol a treatment for liver disease.

Dose

140 mg silybin equivalent, 3× daily (420 mg/day). That requires a standardized extract at 70–80% silymarin — the percentage is the whole game here. Take it with a small meal; a little fat alongside improves absorption. Phytosome-complexed forms (silybin-phosphatidylcholine — the silybin is bound to a fat molecule to ferry it across the gut wall) show 4–10× higher plasma bioavailability, meaning far more of it actually reaches your bloodstream, than standard extract. If you're using the standard extract, the 3× daily schedule is what compensates for the lower absorption. Do not dose simultaneously with acetaminophen at therapeutic doses without physician oversight — silymarin modulates CYP3A4, a major drug-metabolizing enzyme.

Brand

Jarrow Formulas Milk Thistle (30:1 standardized extract, 150 mg capsules, ~120 mg silymarin/cap; ~$18/60 caps). If you'd rather take fewer pills and absorb more per dose, the phytosome upgrade is Thorne Siliphos (silybin-phosphatidylcholine; ~$34/60 tabs) — higher bioavailability, lower pill burden at equivalent dose. That's the one we'd reach for if the budget allows it.

Study

Wah Kheong et al. 2017 (Clinical Gastroenterology and Hepatology, N=99): a double-blind RCT in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH). Silymarin 700 mg/day vs. placebo × 48 weeks. The primary endpoint — improvement in NASH Activity Score — showed a statistically significant reduction in the silymarin arm (p = 0.048). ALT fell ~28% from baseline versus ~12% on placebo. What makes this one matter: it's a hard-endpoint, biopsy-confirmed RCT in a clinically relevant population — not a roomful of healthy volunteers chasing a surrogate marker.

Skip conditions

• Active hormone-sensitive conditions — silymarin has weak estrogenic activity at high doses; human data is limited, but we flag it.
• Concurrent immunosuppressants — tacrolimus, cyclosporine (the CYP3A4 interaction is documented).
• During active chemotherapy: do not add without oncology clearance — CYP modulation affects drug metabolism.

2. NAC — N-Acetylcysteine

In one line: the cheapest, best-validated way to top up glutathione — your liver's master antioxidant — because it hands over the one raw material that's always in short supply.

Mechanism

NAC is the rate-limiting glutathione precursor — "rate-limiting" meaning it's the bottleneck step; supply it and the whole production line speeds up. Hepatic glutathione synthesis needs cysteine, and the cysteine you'd get from dietary protein falls short under high toxic load because it oxidizes too fast to reach your liver cells intact. NAC is a stable, orally bioavailable cysteine source — it survives the trip. Once inside the cell, NAC deacetylates to cysteine → feeds glutathione synthase → raises the hepatic GSH pool.

What's unusual here is how solid the clinical footing is for a supplement ingredient: IV NAC is the standard-of-care treatment for acetaminophen overdose. The reason is exactly this pathway. NAPQI — the toxic Phase I byproduct of acetaminophen — builds up when glutathione runs out, and that's what kills liver tissue. NAC restores glutathione, and the necrosis stops. Your daily maintenance dose is the same machinery running quietly against sub-clinical loads instead of a poisoning.

Dose

600 mg, 2× daily (1,200 mg/day total). Empty stomach absorbs fastest; take it with food if your stomach objects. Sustained-release forms hold plasma levels steadier through the day. One quirk: NAC degrades in solution — if you dissolve it in water, drink it right away. Do not combine with activated charcoal — they absorb each other and cancel out.

Brand

Jarrow Formulas NAC Sustain (600 mg sustained-release; ~$22/100 tabs). Standard-release alternative: NOW Foods NAC 600 mg (~$16/100 caps).

Study

Khoshbaten et al. 2010 (Hepatitis Monthly, N=30): a randomized controlled trial in NAFLD patients. NAC 1,200 mg/day × 12 weeks vs. placebo. ALT fell from a mean of ~73 to ~48 IU/L in the NAC arm versus minimal change on placebo (p < 0.05). The effect is modest in a trial this small — be honest about that — but the mechanistic signal is clean. And the acetaminophen-overdose literature anchors the mechanism at a scale no supplement trial will ever match: Smilkstein et al. 1988 (New England Journal of Medicine, N=2,540) — GSH depletion drives necrosis; NAC restores GSH and prevents it.

Skip conditions

• Active bleeding risk or a pre-surgical window (NAC has mild antiplatelet properties).
• Concurrent nitroglycerin — documented pharmacokinetic interaction that potentiates hypotension.
• Prior bronchospasm with inhaled NAC — rare with the oral form, but still worth flagging if you're asthmatic.
• Above 2,400 mg/day, GI side effects get common. 1,200 mg/day is the practical ceiling for general-adult use.

3. Liposomal Glutathione (Upgrade Tier)

In one line: glutathione delivered directly instead of made on-site — genuinely useful, but only in the forms that actually survive your gut, which is where most "oral glutathione" fails.

Mechanism

Glutathione (GSH) is the primary Phase II conjugation cofactor. It directly grabs electrophilic toxins, heavy-metal ions, and reactive drug metabolites via glutathione S-transferase. The catch with swallowing it has been documented for years: standard reduced glutathione gets chopped up by gut peptidases before it can be absorbed. Older studies using plain oral GSH showed barely a blip in plasma levels — which is why the cynicism around oral glutathione was, for a long time, earned.

Two things changed that. Liposomal delivery wraps the GSH in a phospholipid bilayer — a fatty shell that shields it through the GI tract and delivers it intact to the enterocytes (the cells lining your gut). The Setria-form reduced glutathione solves the same problem a different way. This is the distinction that gets glossed over on labels: "oral glutathione" and "liposomal oral glutathione" are not the same product at standard doses. Richie et al. 2015 (below) is the trial that closed the argument over whether oral GSH absorbs systemically at all — it does, at the right dose, in the right form.

Dose

250–500 mg/day as reduced glutathione, liposomal form, on an empty stomach. If budget is the constraint, NAC (item #2) gets you to the same GSH endpoint more cheaply by building it from precursors. Treat liposomal GSH as the upgrade for people who can't tolerate NAC, or who want to directly verify their blood GSH levels by lab.

Brand

Quicksilver Scientific Liposomal Glutathione (~$60/100 mL; ~1-month supply at 500 mg/day). Prefer capsules? Jarrow Formulas Reduced Glutathione (Setria form, 500 mg; ~$28/60 caps) — not liposomal, but it's the exact ingredient validated in the Richie trial, which is the reason we'd point you there over the dozen unstudied "glutathione" capsules beside it.

Study

Richie et al. 2015 (European Journal of Nutrition, N=54): randomized, double-blind, placebo-controlled. Two doses of oral reduced glutathione (250 mg/day and 1,000 mg/day, Setria form) vs. placebo × 6 months. Whole-blood GSH rose 30–35% in the 1,000 mg/day arm — statistically significant against both baseline and placebo. Erythrocyte and lymphocyte GSH were elevated at the 1,000 mg/day dose by 3 months. This is the study that settled the oral-absorption question; the answer was yes, at sufficient dose, with verified form.

Skip conditions

• Full-dose NAC already in the stack and a tight budget — the endpoint is redundant, so don't pay twice.
• High-dose zinc supplementation (competes for the GSH-mediated detoxification pathway).
• Active chemotherapy — raising GSH may blunt chemotherapeutic cytotoxicity; discuss with your oncologist.

4. Methylated B-Complex

In one line: the B vitamins in the pre-activated forms your body can use right away — which matters because roughly 40% of people carry a gene variant that throttles the conversion from the cheap standard forms.

Mechanism

One-carbon metabolism — the methylation cycle — is a core Phase II pathway. Methyltransferases tag methyl groups onto catecholamines, histamine, heavy metals, and your own metabolites so the liver can ship them out. The supply chain runs like this: dietary folate → 5-methyltetrahydrofolate (5-MTHF) → methionine synthase + B12 → methionine → SAMe (S-adenosylmethionine, the universal methyl donor — the molecule that actually carries the methyl group to wherever it's needed) → methylation reactions → homocysteine → transsulfuration (B6-dependent) → cysteine → which feeds right back into NAC's glutathione pathway. The two halves of this stack talk to each other.

Why the methylated forms specifically: cyanocobalamin, the standard B12 you'll find in most cheap multivitamins, has to be enzymatically converted to methylcobalamin before your body can use it. MTHFR polymorphisms — common gene variants that slow that conversion, present in roughly 40% of the general population at one or more variants — cut that conversion capacity. Methylcobalamin and 5-MTHF skip the conversion step entirely; they're ready to use regardless of your MTHFR status.

Dose

1 capsule of a methylated B-complex daily with breakfast. Minimum doses to look for on the label: methylcobalamin 1,000 mcg; 5-methyltetrahydrofolate (5-MTHF) 400–800 mcg; pyridoxal-5-phosphate (P5P, activated B6) 25–50 mg; riboflavin-5-phosphate 25 mg. Take it with your morning meal — B6 at higher doses is alerting for some people, so keep it off your evening schedule.

Brand

Thorne Basic B (~$24/60 caps) — methylated forms throughout, NSF Certified for Sport, clean excipients. Want more B12? Seeking Health Optimal B12 with L-Methylfolate (~$28/60 caps).

Study

Honest caveat up front: the direct evidence that B-complex supplementation improves liver health in otherwise-healthy adults is mechanistic, not large-RCT. We'd rather say that plainly than dress it up. The strongest human evidence sits one step over, with SAMe in alcoholic liver disease — Mato et al. 1999 (Lancet, N=123): SAMe 1,200 mg/day vs. placebo × 2 years in alcoholic cirrhosis showed a lower mortality/transplant rate in the SAMe arm (trend-level significance). SAMe synthesis sits downstream of the B12/folate methylation cycle, and a B-complex is the upstream substrate support for that cycle. The MTHFR prevalence data (Ogino & Wilson 2003, Journal of the National Cancer Institute) establishes that roughly 40% of the population carries reduced conversion capacity — which is what makes the methylated-form rationale population-relevant rather than an edge case.

Skip conditions

• Active B12 injections — redundant on the B12 component.
• Folate-sensitive cancer histology — methylation-pathway support may be contraindicated; discuss with your oncologist.
• Recent labs showing B12 and folate in robust range on a whole-food diet — the marginal benefit is low.

5. Choline Bitartrate

In one line: the cheap, overlooked nutrient your liver needs to export fat — skimp on it and triglycerides start backing up in the liver itself.

Mechanism

Choline is the most underappreciated item on this list, and the cheapest, which is a frustrating combination. The liver needs choline to build phosphatidylcholine, and phosphatidylcholine is what packages fat into VLDL particles for export out of the liver. Run short on choline and triglycerides accumulate in the hepatocytes instead of leaving — that backup is the biochemical opening act of non-alcoholic fatty liver disease (NAFLD). And this isn't extrapolated from rodents: it was demonstrated in controlled dietary-deprivation studies in healthy human volunteers.

Choline pulls double duty as a methyl donor through the betaine/BHMT pathway, feeding back into the Phase II methylation cycle from item #4. It's classified as a dietary essential with a defined Adequate Intake — 550 mg/day for adult males, 425 mg/day for adult females. Most adults who aren't eating eggs and liver regularly don't hit that number from food alone.

Dose

500 mg/day as choline bitartrate with any meal. For documented fatty liver or NAFLD, 1,000 mg/day may be warranted — discuss it with your physician. Doses above 3,500 mg/day produce a fishy body odor via the TMAO pathway; this protocol's dose sits well under that line.

Brand

NOW Foods Choline & Inositol 500 mg (~$12/100 caps). Straightforward, third-party tested. The inositol that comes along for the ride is harmless but not why you're buying it.

Study

Zeisel et al. 2007 (FASEB Journal, N=57): healthy adult volunteers put on a defined choline-deficient diet. Within 3 weeks, 77% of the men and postmenopausal women developed measurable liver dysfunction — AST/ALT elevation plus hepatic fat on imaging. Reintroducing dietary choline reversed those deficiency-induced lab and imaging changes in that controlled setting. Buchman et al. 2001 (Hepatology, N=15) replicated the same mechanism in total-parenteral-nutrition patients who weren't getting choline. The takeaway is blunt but bounded: choline deficiency can cause reversible hepatic-fat changes in humans, but choline is not a standalone NAFLD treatment.

Skip conditions

• Trimethylaminuria (TMAU) — a rare enzyme deficiency that causes fishy odor even at standard choline doses; choline restriction is the indicated move in TMAU.
• Renal insufficiency — choline is renally excreted; discuss the dose with your physician.
• Choline-sensitive atrial fibrillation — a theoretical concern via the acetylcholine pathway; human data is limited, but we flag it.

What to Cut — and Why

The cut-list is load-bearing here, not filler. Buyers in this category routinely over-stack on products with no defensible mechanism in the Phase II pathway this protocol targets. Clearing these out before you add the five above saves money and avoids interference — and in a couple of cases it's the difference between a working stack and a self-canceling one.

Detox Teas and Herbal Cleanse Kits

The claim: "flush the liver," "stimulate detoxification." What's actually happening: a laxative effect — usually senna, cascara, or rhamnus — produces GI urgency that feels like cleansing. There's no evidence of Phase I or Phase II liver-enzyme modulation at the doses found in commercial tea products. The claim is anatomically confused at its root: the colon is not the liver, and emptying one does nothing for the other.

Activated Charcoal (Daily Maintenance Doses)

Credit where it's due — activated charcoal binds toxins in the gut, and that's a real, appropriate mechanism in acute poisoning, in an emergency, under supervision. Taken daily at maintenance doses, though, it binds indiscriminately: your fat-soluble vitamins, your medications, and your NAC if you took it in the same window. It does not know what a "toxin" is. Daily use in healthy adults buys you nutrient depletion and drug interference with no documented liver-function benefit on the other side.

Olive Oil "Gallbladder Flush"

The ritual: down large volumes of olive oil and citrus juice overnight, then collect the "gallstones" you pass the next day. Those "stones" are olive-oil/citrus soap balls that form in the GI tract during the flush — not gallstones. Fatty-acid composition analysis of the passed "stones" confirmed it. Real gallstones are calcium bilirubinate or cholesterol crystals; they aren't olive green and they don't dissolve in the intestine. The flush does nothing to liver function.

Dandelion Root for Liver

Pull the studies cited in dandelion-root marketing and the pattern is consistent: N < 20, no placebo control, or animal-model extrapolation. No randomized controlled trial in humans has shown liver-enzyme normalization, Phase II enzyme upregulation, or any measurable hepatic endpoint from dandelion root. The bile-secretion mechanism people cite rests on a single in vitro study. Skip it until the evidence base changes.

Proprietary "Liver Support" Blends at Sub-Threshold Doses

These are the 10-to-12-ingredient blends at sub-effective doses. The tell is always the same: silymarin at 50 mg (the threshold for any documented effect is 420+ mg/day), NAC at 150 mg (threshold is 1,200 mg/day), and eight more ingredients at essentially homeopathic doses. A blend with silymarin at 50 mg is not silymarin's documented mechanism — it's the word "silymarin" on a label. Check every ingredient against its evidence-based dose before you pay for the bottle.

Standard Oral Curcumin / Turmeric (Without Bioavailability Delivery)

Standard curcumin has near-zero oral bioavailability — plasma levels after standard oral curcumin are undetectable in most pharmacokinetic studies, meaning almost none of it reaches your blood. Piperine co-administration helps meaningfully, and phospholipid-complexed or nanoparticle forms have validated bioavailability. If a curcumin product doesn't spell out a bioavailability-enhancement system, it's functionally a placebo at standard doses. And there's a sharper reason to leave it out of this protocol specifically: curcumin carries documented drug-induced liver injury (DILI) case reports at high doses. Putting an ingredient with liver-injury reports into a liver-support stack, with no compelling RCT to justify it, is a risk/benefit calculation that lands in the negative.

Frequently Asked Questions

Do I have to take all five items, or can I start with fewer?

Start with silymarin + NAC + methylated B-complex + choline. Those four cover the four main Phase II bases — glutathionation, upstream GSH synthesis, methylation, and phosphatidylcholine export — for a combined ~$70–90/month. Add liposomal glutathione later as an upgrade once the entry stack is running. The entry four carry the strongest individual evidence bases; liposomal glutathione layers on a direct GSH delivery route if you want to verify blood GSH elevation or you can't tolerate NAC.

How long before I see a change in liver enzymes?

Set expectations honestly: the silymarin RCT (Wah Kheong 2017) ran 48 weeks, and the NAC NAFLD trial (Khoshbaten 2010) ran 12 weeks. In a general-adult population with no diagnosed liver disease, you will not feel anything — and you shouldn't expect to. The point of this protocol isn't a subjective experience; it's Phase II throughput maintenance and steady substrate supply. If elevated ALT/AST is what brought you here, recheck labs at 12 weeks with the entry four in place and compare to baseline.

Is this safe to take with medications?

Three interactions worth clearing before you start:

1. Silymarin + CYP3A4-metabolized drugs (tacrolimus, cyclosporine, some statins, some chemotherapy) — silymarin modulates that enzyme family; talk to your prescriber.
2. NAC + nitroglycerin — a documented pharmacokinetic interaction (hypotension potentiation).
3. Any item in this stack + acetaminophen at therapeutic doses — the Phase II glutathionation overlap warrants a physician conversation if you're managing chronic acetaminophen use.

For general-adult populations on no chronic medications, the entry stack has a strong safety profile at the doses listed.

Why is the cut-list so long for liver supplements specifically?

Because the liver-cleanse market has the highest concentration of mechanism-empty products in the entire supplement industry — and the reason is structural. The promised outcome, "detoxification," is invisible. Nobody can feel their Phase II enzymes running. A category whose payoff can't be sensed is a category wide open to products that sell the outcome without owning any operative mechanism. The cut-list is proportionally long because the correction it answers is proportionally large.

Does this protocol treat liver disease?

No. This is a daily-maintenance stack for general-adult populations supporting Phase II conjugation throughput. The silymarin RCT did enroll patients with biopsy-confirmed NASH — but that doesn't make this protocol a treatment. It makes silymarin a candidate worth raising in a clinical-management conversation with a gastroenterologist. If you have elevated liver enzymes, diagnosed hepatic steatosis, or any liver condition, see your physician before adding any of these items.

What about TUDCA? I've seen it recommended for liver health.

TUDCA (tauroursodeoxycholic acid) has a real mechanism — it's a hydrophilic bile acid that reduces endoplasmic reticulum stress and has documented hepatoprotective effects in cholestatic liver disease models. The honest problem is the population: the evidence in general adults without biliary pathology is thin. The clearest human data sits in bariatric surgery patients (fewer gallstones forming post-surgery) and in ALS trials (which are neurological, not hepatic). It's genuinely worth watching as the data matures. It didn't make this version of the stack because the general-adult indication isn't RCT-supported yet at the level of the five that did. The moment that changes, we'll add it.

Affiliate Disclosure

Stack-kit earns affiliate commission when you purchase products through links on this page. That's how the publication is funded. The compensation structure does not influence which products appear in protocols or what order they're listed — every item earns its position by meeting the evidence and specification standards described in the mechanism sections above. If a higher-margin product doesn't pass those standards, it isn't here. If a lower-margin product has the best evidence, it leads the recommendation. You can verify this by checking any item in the cut-list — several of those products would pay higher commission than items we included.

Prices shown are approximate and change. Verify current pricing at point of purchase.